ABVC
ABVC BioPharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website abvcpharma.com
- Employees(FY) 19
- ISIN US00091F3047
Performance
-2.73%
1W
-4.46%
1M
-15.75%
3M
-32.7%
6M
-7.76%
YTD
-86.1%
1Y
Profile
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.
Technical Analysis of ABVC 2024-05-10
Overview:
In analyzing the technical indicators for ABVC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-17 10:52
- 2024-05-14 23:14
- 2024-05-14 21:25
- 2024-05-08 21:35
- 2024-04-17 21:25
- 2024-04-16 21:00
- 2024-04-09 20:30
- 2024-03-25 20:30
- 2024-03-20 20:30
- 2024-03-18 20:30
- 2024-03-13 21:30
- 2024-02-26 19:30
- 2024-02-14 19:30
- 2024-02-11 19:30
- 2024-02-07 20:17
- 2024-01-02 18:24
- 2023-12-06 19:30
- 2023-12-04 19:30
- 2023-11-20 19:30
- 2023-11-15 21:05
- 2023-11-14 20:00
- 2023-10-25 20:30
- 2023-10-16 20:30
- 2023-10-08 20:30
- 2023-08-22 20:30
- 2023-08-16 21:19
- 2023-08-09 20:30
- 2023-08-06 20:30
ABVC Corporate Update and CEO's Letter to Shareholders(Yahoo Finance)
- 2023-08-02 21:20
- 2023-07-31 20:30
Page 1 of 4
previousnext